INSIDER
Karmanos Cancer Institute to receive first FDA-approved SoftVue system
Read full article: Karmanos Cancer Institute to receive first FDA-approved SoftVue systemForty percent of women have dense breast tissue, putting them at higher risk for breast cancer and making the disease more difficult to detect with a mammogram.